Literature DB >> 31953183

Angiogenic circular RNAs: A new landscape in cardiovascular diseases.

Tian-Rong Zhang1, Wei-Qiang Huang2.   

Abstract

Angiogenesis refers to the formation of new blood vessels from existing blood vessels, including endothelial progenitor cells differentiation and cytokine regulation. Circular RNAs, a type of non-coding RNA, are a stable and conservative endogenous transcriptional product with a circular structure that is produced by the reverse and scrambled splicing of mRNA precursors. They can be used as microRNA sponges, are involved in transcription and protein translation, and regulate the pathophysiological processes of various diseases. Recent studies have shown that circRNAs can regulate angiogenesis by regulating vascular endothelial cell function. In this review, we summarize the angiogenic mechanism; the biogenesis, properties and biological function of circRNAs; and their roles in regulating angiogenesis. We also discuss their potential implications for clinical applications.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Angiogenesis; Biomarker; Cardiovascular diseases; Circular RNAs; Endothelial cells; Therapeutic target

Year:  2020        PMID: 31953183     DOI: 10.1016/j.mvr.2020.103983

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  3 in total

1.  CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.

Authors:  Xiaoqin Li; Xuemei Jiang; Jing Lu; Yuting Lin; Lan Jiang; Yan Li; Feng Wan; Changmin Wang
Journal:  Biochem Genet       Date:  2022-06-08       Impact factor: 1.890

2.  Non-coding RNAs in Neonatal Necrotizing Enterocolitis.

Authors:  Keyur Donda; Benjamin A Torres; Akhil Maheshwari
Journal:  Newborn (Clarksville)       Date:  2022-03-31

Review 3.  The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases.

Authors:  Kai Wang; Xiang-Qian Gao; Tao Wang; Lu-Yu Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-16       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.